Orphan drug sales to become 1/5 of the market.
Worldwide Orphan Drug sales are expected to grow to
$178b (up from $97b in 2014) in 2020 making up 20% of
the total drug market.
Source: Worldwide Orphan Drug Sales (2000-2020),
Evaluatepharma, 30 September 2015
Compiled by Cari Kraft, Jacobs Management Group, Inc.
BY THE NUMBERS
Pharma’s average cost to develop 1 drug.
Only 11.8% of products that enter clinical testing
reach regulatory approval. If a new drug does
make it through to market approval, the total cost
through R&D, testing and failures is $2.6b
Source: Innovation in Drug Development Process
Remains a Key Challenge, Tufts Center for the Study
of Drug Development, October 20, 2015
$48b dollars in drugs will go.
Drugs that are expected to go the 2015 off-patent cliff
will contribute to just under $48B for pharmaceutical
revenue. However, the FDA approved 44 drugs in total
to be launched in which $58b are expected to counter
Source: Patent Cliff II is here, But do Pharmacy Chains
Need to Worry?, Trefis®, Feb 24, 2015